Moriyama, B., Falade, O., Leung, J., Penzak, S. R., JJingo, C., Huang, X., . . . Walsh, T. J. (2011). Prolonged Half-life of Voriconazole in a CYP2C19 Homozygous Poor Metabolizer Receiving Vincristine Chemotherapy: Avoiding a Serious Adverse Drug Interaction.
Chicago Stili AlıntıMoriyama, Brad, Oluwaseun Falade, Janice Leung, Scott R. Penzak, Caroline JJingo, Xuan Huang, Stacey A. Henning, Wyndham H. Wilson, ve Thomas J. Walsh. Prolonged Half-life of Voriconazole in a CYP2C19 Homozygous Poor Metabolizer Receiving Vincristine Chemotherapy: Avoiding a Serious Adverse Drug Interaction. 2011.
MLA AlıntıMoriyama, Brad, et al. Prolonged Half-life of Voriconazole in a CYP2C19 Homozygous Poor Metabolizer Receiving Vincristine Chemotherapy: Avoiding a Serious Adverse Drug Interaction. 2011.